U.S. flag

An official website of the United States government

NM_207122.2(EXT2):c.667C>T (p.Arg223Trp) AND Exostoses, multiple, type 2

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Mar 3, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001941353.6

Allele description [Variation Report for NM_207122.2(EXT2):c.667C>T (p.Arg223Trp)]

NM_207122.2(EXT2):c.667C>T (p.Arg223Trp)

Gene:
EXT2:exostosin glycosyltransferase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p11.2
Genomic location:
Preferred name:
NM_207122.2(EXT2):c.667C>T (p.Arg223Trp)
HGVS:
  • NC_000011.10:g.44114225C>T
  • NG_007560.1:g.23677C>T
  • NM_000401.3:c.766C>T
  • NM_001178083.3:c.667C>T
  • NM_001389628.1:c.667C>T
  • NM_001389630.1:c.667C>T
  • NM_207122.2:c.667C>TMANE SELECT
  • NP_000392.3:p.Arg256Trp
  • NP_001171554.1:p.Arg223Trp
  • NP_001376557.1:p.Arg223Trp
  • NP_001376559.1:p.Arg223Trp
  • NP_997005.1:p.Arg223Trp
  • LRG_494t1:c.766C>T
  • LRG_494:g.23677C>T
  • LRG_494p1:p.Arg256Trp
  • NC_000011.9:g.44135775C>T
  • NM_207122.1:c.667C>T
Protein change:
R223W
Links:
dbSNP: rs201062014
NCBI 1000 Genomes Browser:
rs201062014
Molecular consequence:
  • NM_000401.3:c.766C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001178083.3:c.667C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001389628.1:c.667C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001389630.1:c.667C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_207122.2:c.667C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Exostoses, multiple, type 2 (EXT2)
Synonyms:
EXOSTOSES, MULTIPLE, TYPE II
Identifiers:
MONDO: MONDO:0007586; MedGen: C1851413; Orphanet: 321; OMIM: 133701

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002223603Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Nov 27, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

SCV004192807Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Mar 3, 2024)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutation screening of the EXT genes in patients with hereditary multiple exostoses in Taiwan.

Shi YR, Wu JY, Hsu YA, Lee CC, Tsai CH, Tsai FJ.

Genet Test. 2002 Fall;6(3):237-43.

PubMed [citation]
PMID:
12490068

Evaluation of the anatomic burden of patients with hereditary multiple exostoses.

Alvarez CM, De Vera MA, Heslip TR, Casey B.

Clin Orthop Relat Res. 2007 Sep;462:73-9.

PubMed [citation]
PMID:
17589361
See all PubMed Citations (6)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002223603.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 223 of the EXT2 protein (p.Arg223Trp). This variant is present in population databases (rs201062014, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with EXT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1441831). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt EXT2 protein function with a positive predictive value of 80%. This variant disrupts the p.Arg223 amino acid residue in EXT2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12490068, 17589361, 18165274, 23262345). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV004192807.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024